Compounding group sues FDA for removing Lilly's weight loss drug from shortage list
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...
Woman's World on MSN2h
Enter to Win a Dyson Supersonic in The Woman's World Weight Loss Survey Sweepstakes
The Woman's World staff have been working hard to untangle the complicated and fast moving world of prescription weight loss ...
Huzur Devletsah
Turkey's Huzur Devletsah is the first woman to head Eli Lilly's China affiliate since the U.S. pharma maker began operations ...
24/7 Wall St. on MSN5h
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 584.52% and ...
3 Momentum Trades Too Good Pass Up
Momentum investing is based on the idea that stocks that have risen recently will tend to keep rising and that stocks that ...
Hims & Hers Health Stock Is Rising Monday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...
Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Momentum Stock Now
We recently compiled a list of the 8 Best Momentum Stocks To Invest In Right Now. In this article, we are going to take a ...
Medscape15h
Tirzepatide Shortage Resolved? FDA Says Yes, Compounders No
Tirzepatide injection (Zepbound, Mounjaro) is officially off the FDA's drug shortage list, meaning compounders can no longer prepare and dispense the drug.